UPDATE: Jefferies Starts Werewolf Therapeutics Inc. (HOWL) at Buy, 'Call of the Wild-Type IL-2'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. AVGO
2. CDNS
3. SPY
4. META
5. JBLU
6. ANT
7. SSD
8. ARTV
9. AAPL
10. INTC

Go back to UPDATE: Jefferies Starts Werewolf Therapeutics Inc. (HOWL) at Buy, 'Call of the Wild-Type IL-2'

'Cancer's Worst Nightmare': Street Bullish on Werewolf Therapeutics (HOWL) Amid Sustainable Growth Prospects

May 25, 2021 8:43 AM EDT

At least four Wall Street firms have started coverage on Werewolf Therapeutics (NASDAQ: HOWL) with bullish views on the company.

The company raised $120 million in its Wall Street debut in April after it ended 2020 with $93 million in the bank. In January, the company raised $72 million to further boost its balance sheet. In the IPO, Wolf sold 7.5 million shares at $16 each, a million more shares than previously communicated.

Jefferies analyst Chris Howerton starts with... More